CD13 Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90070r-50uL |
| Product Name | CD13 Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human CD13 |
| Immunogen Range | 400-464/967 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20°C |
| Target | |
| Gene ID | 290 |
| Swiss Prot | P15144 |
| Synonyms | ANPEP; Alanyl Aminopeptidase Membrane; AP-N; HAPN; Microsomal Aminopeptidase; Aminopeptidase N; Aminopeptidase M; LAP1; P150; CD13; PEPN; Myeloid Plasma Membrane Glycoprotein CD13; Alanyl (Membrane) Aminopeptidase; Membrane Alanyl Aminopeptidase; EC 3.4.11.2; Gp150; GP150; AP-M; APN; Alanyl; Aminopeptidase; CD13 Antigen; EC 3.4.11 |
| Background | Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |